These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1373750)

  • 21. Substance P- and antigen-induced release of leukotriene B4, prostaglandin D2 and histamine from guinea pig skin by different mechanisms in vitro.
    Furutani K; Koro O; Hide M; Yamamoto S
    Arch Dermatol Res; 1999; 291(7-8):466-73. PubMed ID: 10482019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study.
    Messamore E; Hoffman WF; Janowsky A
    Schizophr Res; 2003 Aug; 62(3):251-8. PubMed ID: 12837522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The IgE- and calcium-dependent release of eicosanoids and histamine from human purified cutaneous mast cells.
    Robinson C; Benyon C; Holgate ST; Church MK
    J Invest Dermatol; 1989 Sep; 93(3):397-404. PubMed ID: 2504819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin D2 release by guinea pig skin during in vitro anaphylaxis induced by antigen and compound 48/80.
    Kozuka T; Francis DM; Barr RM; Numata T; Mallet AI; Greaves MW
    J Invest Dermatol; 1987 Feb; 88(2):115-9. PubMed ID: 2433354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exogenous fatty acids and niacin on acute prostaglandin D
    Montserrat-de la Paz S; Bermudez B; Lopez S; Naranjo MC; Romero Y; Bando-Hidalgo MJ; Abia R; Muriana FJG
    J Nutr Biochem; 2017 Jan; 39():22-31. PubMed ID: 27741434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profile of prostanoid release following antigen challenge in vivo in the skin of man.
    Massey WA; Hubbard WC; Liu MC; Kagey-Sobotka A; Cooper P; Lichtenstein LM
    Br J Dermatol; 1991 Dec; 125(6):529-34. PubMed ID: 1760357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2.
    Giles H; Bolofo ML; Lydford SJ; Martin GR
    Br J Pharmacol; 1991 Oct; 104(2):541-9. PubMed ID: 1665742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The flavonoid luteolin inhibits niacin-induced flush.
    Papaliodis D; Boucher W; Kempuraj D; Theoharides TC
    Br J Pharmacol; 2008 Apr; 153(7):1382-7. PubMed ID: 18223672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats.
    Eguchi N; Kaneko T; Urade Y; Hayashi H; Hayaishi O
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1110-20. PubMed ID: 1527717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Niacin skin flush in schizophrenia: a preliminary report.
    Ward PE; Sutherland J; Glen EM; Glen AI
    Schizophr Res; 1998 Feb; 29(3):269-74. PubMed ID: 9516668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of prostaglandin D2 on the response of human skin to histamine.
    Maurice PD; Barr RM; Koro O; Greaves MW
    J Invest Dermatol; 1987 Sep; 89(3):245-8. PubMed ID: 3476674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms.
    Dishy V; Liu F; Ebel DL; Atiee GJ; Royalty J; Reilley S; Paolini JF; Wagner JA; Lai E
    J Clin Pharmacol; 2009 Apr; 49(4):416-22. PubMed ID: 19246721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerance to nicotinic acid flushing.
    Stern RH; Spence JD; Freeman DJ; Parbtani A
    Clin Pharmacol Ther; 1991 Jul; 50(1):66-70. PubMed ID: 1855354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli.
    Benyon RC; Robinson C; Church MK
    Br J Pharmacol; 1989 Jul; 97(3):898-904. PubMed ID: 2474353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1.
    Lai E; De Lepeleire I; Crumley TM; Liu F; Wenning LA; Michiels N; Vets E; O'Neill G; Wagner JA; Gottesdiener K
    Clin Pharmacol Ther; 2007 Jun; 81(6):849-57. PubMed ID: 17392721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells: roles of cytosolic calcium and protein tyrosine kinases.
    van Haaster CM; Engels W; Lemmens PJ; Hornstra G; van der Vusse GJ; Heemskerk JW
    Biochim Biophys Acta; 1995 Feb; 1265(1):79-88. PubMed ID: 7857988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin D2 and histamine release in cold urticaria.
    Heavey DJ; Kobza-Black A; Barrow SE; Chappell CG; Greaves MW; Dollery CT
    J Allergy Clin Immunol; 1986 Sep; 78(3 Pt 1):458-61. PubMed ID: 2428856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells.
    Wang XS; Lau HY
    Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):746-50. PubMed ID: 16895550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
    Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
    Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of prostaglandin D2 and its analogues on intraocular pressure in rabbits.
    Goh Y; Nakajima M; Azuma I; Hayaishi O
    Jpn J Ophthalmol; 1988; 32(4):471-80. PubMed ID: 3236567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.